Find information about using LOINC codes for SARS-CoV-2 tests
- LOINCs for commercial in vitro diagnostics (IVD) test kits
- Help with choosing the right LOINC
- Frequently Asked Questions
- External links related to COVID-19
- Video webinar
View LOINC Special Use terms for SARS-CoV-2 on our Prerelease page
Special Use codes are developed in response to an urgent or emergent situation. These codes are based on the most up to date information available at the time of their creation. They have undergone the normal QA terminology process. LOINC supports their use in the unique situation that resulted in their rapid creation. However, be aware that downstream users may not be ready to handle prerelease codes until they are published in an official release.
The international standard for identifying health measurements, observations, and documents.
Reference labs, healthcare organizations, U.S. federal agencies, insurance companies, software vendors, in vitro diagnostic testing companies, and more than 93,800 registered users from 179 countries use LOINC to move data seamlessly between systems.
In-person events for the 2020 LOINC Conference in Indianapolis have been canceled
You may still register to attend the public LOINC Committee Meetings for online attendance. Read more about this announcement. UPDATE 2020-03-16: Both public LOINC Committee Meetings have been postponed.
Seeking Director of LOINC and Health Data Standards
Apply to lead the LOINC program at Regenstrief Institute.
New DRAFT guide for using Drug and Toxicology LOINC terms
This new guide is now available for download and review.
Call for committee meeting agenda items
Send your suggested agenda items for the public Laboratory and Clinical committee meetings—tentatively scheduled for late April or early May.